Branched Stent Grafts Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report 2026-2030

Branched stent grafts are specialized endovascular prostheses used to repair complex abdominal and thoracic aortic aneurysms that involve major branch vessels, such as the renal, mesenteric, and iliac arteries. These devices enable minimally invasive treatment while maintaining blood flow to critical organs, offering an alternative to high-risk open surgical repair. The global market, valued at approximately $0.45 billion in 2025, encompasses fenestrated and branched endografts, custom-made devices, and off-the-shelf modular systems.

• •Used primarily for complex aortic aneurysms requiring preservation of branch vessel blood flow
• •Includes fenestrated stent grafts with openings for side branches and fully branched configurations
• •Represents a high-value specialized segment within the endovascular aneurysm repair market

The market growth is primarily fueled by the increasing global prevalence of aortic aneurysms, particularly among aging populations, and the expanding adoption of endovascular techniques over traditional open surgery. Technological innovations in stent graft design, including improved deliverability, better sealing mechanisms, and expanded sizing options, have broadened the treatable patient population. Additionally, favorable clinical outcomes data, reduced procedural mortality, and shorter hospital stays compared to open repair continue to drive physician and patient preference toward branched endovascular solutions.

• •Rising incidence of aortic aneurysms among elderly populations worldwide
• •Clinical advantages of minimally invasive endovascular repair over open surgical procedures
• •Technological improvements in device design, customization, and procedural techniques

The market is segmented by product type, including aortic branched stent grafts, iliac branched stent grafts, and custom fenestrated devices, with aortic applications representing the largest segment. Geographically, North America and Europe currently dominate the market due to advanced healthcare infrastructure, high procedure volumes, and favorable reimbursement environments. The Asia-Pacific region is expected to witness the fastest growth, driven by rising healthcare expenditure, increasing awareness of endovascular procedures, and growing medical tourism in countries like China, India, and Japan.

• •Product segmentation includes aortic stent grafts, peripheral stent grafts, and specialized custom devices
• •North America leads in market share due to established healthcare systems and high procedure adoption
• •Asia-Pacific emerging as the fastest-growing region due to expanding healthcare access and rising procedural volumes

What are the recent trends and outlook?

The market outlook through 2031 suggests continued robust growth, with the global market expected to expand significantly from its 2025 baseline as technology advances and indications broaden. Key trends include increasing adoption of off-the-shelf branched devices to reduce customization lead times, integration of advanced imaging and navigation technologies for precise deployment, and expansion of indications to include more complex thoracoabdominal aneurysms. The growing emphasis on value-based healthcare and outcomes-driven reimbursement models is expected to further accelerate market adoption as clinical evidence supporting branched endovascular repair continues to mature.

• •Shift toward off-the-shelf modular systems to reduce manufacturing time and improve accessibility
• •Integration of intraoperative imaging and computational planning tools for enhanced procedural precision
• •Expanding clinical indications and growing evidence base supporting broader patient eligibility